Alexion Pharmaceutic
ALXN
Real-time BATS EXCHANGE - 05/25 01:06:39 pm
117.42USD
+0.24%
Prev.118.1300
Open118.2800
High118.9500
Low116.4600
Volume1 139 595
Financials
Sales 2018 4 000 M
EBIT 2018 1 954 M
R. net 2018 480 M
Debt 2018 1 400 M
Rend. 2018 -
P/E ratio 2018 47,84
P/E ratio 2019 18,72
EV / Sales 2018 6,87x
EV / Sales 2019 4,90x
Capitalization 26 064 M
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.Its products include soliris, strensiq and kanuma.The company was founded...
Sector :
Biopharmaceuticals
Calendar :
2018-07-26 Earnings Release
Trading Rating :
Investor Rating :
Latest news
12:49pALEXION : Wilson Therapeutics Holders Accept Offer
DJ
05/24Kiniksa upsizes IPO, raises $152.6M
AQ
05/15ALEXION PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
AQ
05/11ALEXION PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/08ALEXION PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
BU
04/30Ex-Synageva team planning Kiniksa IPO
AQ
04/26ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
04/26ALEXION PHARMACEUTICALS : Alexion Pharmaceuticals, Inc. to Host Earnings Call
AC
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBearish
Resistance123128127
Spread/Res.-4,6%-8,5%-7,6%
Spread/Supp.2,9%10%8,7%
Support114106108